Biogen Correlations

BIIB Stock  USD 191.82  3.80  2.02%   
The current 90-days correlation between Biogen Inc and Incyte is -0.09 (i.e., Good diversification). The correlation of Biogen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Biogen Correlation With Market

Very weak diversification

The correlation between Biogen Inc and DJI is 0.43 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Biogen Inc and DJI in the same portfolio, assuming nothing else is changed.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

Moving together with Biogen Stock

  0.73PYC Physiomics Plc Earnings Call This WeekPairCorr

Moving against Biogen Stock

  0.62OSE OSE Pharma SAPairCorr
  0.62RAC Race OncologyPairCorr
  0.55VCYT VeracytePairCorr
  0.49VANI Vivani MedicalPairCorr
  0.62DRMA Dermata TherapeuticsPairCorr
  0.56DXB DimerixPairCorr
  0.45PHARM Pharming Group NVPairCorr
  0.36DTIL Precision BioSciencesPairCorr
  0.35ABNX Abionyx Pharma SA Earnings Call This WeekPairCorr
  0.759OF BIORESTORATTHERAPDLPairCorr
  0.62BIM Biomerieux SAPairCorr
  0.55IGS1 India GlobalizationPairCorr
  0.5DYAI Dyadic InternationalPairCorr
  0.43VKTX Viking TherapeuticsPairCorr
  0.34DWTX Dogwood TherapeuticsPairCorr

Related Correlations Analysis


Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

DGXLH
DXCMTEVA
PODDWAT
WATSTE
WATGMAB
STEGMAB
  

High negative correlations

PODDTEVA
DGXWAT
PODDDXCM
DGXGMAB
WATLH
GMABLH

Risk-Adjusted Indicators

There is a big difference between Biogen Stock performing well and Biogen Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Biogen's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
INCY  1.57  0.00 (0.04) 0.13  2.36 
 4.10 
 13.76 
LH  1.03  0.11  0.04  0.42  1.19 
 2.63 
 7.89 
GMAB  1.73 (0.12) 0.00 (0.04) 0.00 
 3.39 
 9.44 
UTHR  1.26  0.06  0.01  0.19  1.52 
 2.00 
 18.91 
TEVA  1.18  0.46  0.39  0.79  0.58 
 3.58 
 8.88 
DXCM  1.29  0.25  0.14  0.45  1.20 
 3.31 
 9.82 
STE  1.02 (0.14) 0.00 (0.05) 0.00 
 1.79 
 10.43 
WAT  1.22 (0.39) 0.00 (0.28) 0.00 
 2.50 
 17.35 
PODD  1.49 (0.48) 0.00 (0.92) 0.00 
 2.79 
 8.24 
DGX  1.13  0.17  0.07 (4.30) 0.97 
 2.75 
 8.55 

Biogen Corporate Executives

Elected by the shareholders, the Biogen's board of directors comprises two types of representatives: Biogen inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Biogen. The board's role is to monitor Biogen's management team and ensure that shareholders' interests are well served. Biogen's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Biogen's outside directors are responsible for providing unbiased perspectives on the board's policies.
Michael CPAExecutive CFOProfile